The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray as the first and only monotherapy for adults with major depressive ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

They can help you find out if a nasal spray may be beneficial for your acute migraine symptoms. They can also inform you of any side effects or interactions to watch out for. Healthline has strict ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

It is also important to consider the ingredients in the allergy nasal spray. Some sprays contain steroids, which can have side effects, while others contain natural ingredients like saline or ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...